MedKoo Cat#: 558623 | Name: Metanilic acid
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Metanilic acid is an anti-cancer drug used to treat several malignancies including pediatric acute lymphoblastic leukemia and choriocarcinoma.

Chemical Structure

Metanilic acid
CAS#121-47-1 (free acid)

Theoretical Analysis

MedKoo Cat#: 558623

Name: Metanilic acid

CAS#: 121-47-1 (free acid)

Chemical Formula: C6H7NO3S

Exact Mass: 173.0147

Molecular Weight: 173.19

Elemental Analysis: C, 41.61; H, 4.07; N, 8.09; O, 27.71; S, 18.51

Price and Availability

Size Price Availability Quantity
25g USD 250.00 2 weeks
100g USD 450.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Synonym
Metanilic acid; m-Anilinesulfonic acid; m-Sulfanilic acid;
IUPAC/Chemical Name
3-Aminobenzenesulphonic acid
InChi Key
ZAJAQTYSTDTMCU-UHFFFAOYSA-N
InChi Code
InChI=1S/C6H7NO3S/c7-5-2-1-3-6(4-5)11(8,9)10/h1-4H,7H2,(H,8,9,10)
SMILES Code
O=S(C1=CC=CC(N)=C1)(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info
Product Data
Biological target:
Metanilic acid is an anti-cancer drug.
In vitro activity:
TBD
In vivo activity:
TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 173.19 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
TBD
In vitro protocol:
TBD
In vivo protocol:
TBD
1: Valli Nachiyar C, Vijayalakshmi K, Muralidharan D, Suseela Rajakumar G. Mineralization of metanilic acid by Pseudomonas aeruginosa CLRI BL22. World J Microbiol Biotechnol. 2007 Dec;23(12):1733-8. doi: 10.1007/s11274-007-9422-7. Epub 2007 May 18. PubMed PMID: 27517829. 2: Stefănescu E, Gheorghită N, Pavelescu M, Pĭsaroc-Doru G. [Linkage of anthranilic and metanilic acid salts of diazonium to pyrazolones]. Rev Med Chir Soc Med Nat Iasi. 1985 Apr-Jun;89(2):313-5. Romanian. PubMed PMID: 3911321. 3: Farouk R, Gaffer HE. Simultaneous dyeing and antibacterial finishing for cotton cellulose using a new reactive dye. Carbohydr Polym. 2013 Aug 14;97(1):138-42. doi: 10.1016/j.carbpol.2013.04.037. Epub 2013 Apr 23. PubMed PMID: 23769529. 4: Rádek O, Kejha J, Nĕmecek O, Kakác B. [Contrast media. V. Iodinated derivatives of metanilic acid]. Cesk Farm. 1968 Jul;17(6):272-6. Czech. PubMed PMID: 5699389. 5: Valli Nachiyar C, Suseela Rajakumar G. Mechanism of Navitan Fast Blue S5R degradation by Pseudomonas aeruginosa. Chemosphere. 2004 Oct;57(3):165-9. PubMed PMID: 15312732. 6: Yang Y, Min Y, Wu JC, Hansford DJ, Feinberg SE, Epstein AJ. Synthesis and characterization of cytocompatible sulfonated polyanilines. Macromol Rapid Commun. 2011 Jun 16;32(12):887-92. doi: 10.1002/marc.201100095. Epub 2011 May 17. PubMed PMID: 21590992. 7: Sarayu K, Sandhya S. Aerobic biodegradation pathway for Remazol Orange by Pseudomonas aeruginosa. Appl Biochem Biotechnol. 2010 Feb;160(4):1241-53. doi: 10.1007/s12010-009-8592-1. Epub 2009 Mar 10. PubMed PMID: 19277481. 8: De Beer JO, Dierickx PJ, Grimée RI. N-acetyl-(1-amino-2-naphthol-6-sulphonic acid), a common metabolite of sunset yellow FCF, orange GGN and 1-amino-2-naphthol-6-sulphonic acid in rat urine. J Chromatogr. 1982 Mar 5;237(1):115-25. PubMed PMID: 7068792. 9: Singh RL. Metabolic disposition of [14C] metanil yellow in rats. Biochem Int. 1989 Nov;19(5):1109-16. PubMed PMID: 2635853. 10: Mimura T, Nakamura Y, Nishino J, Sawayama T, Komiya T, Deguchi T, Kita A, Nakamura H, Matsumoto J. A novel class of enkephalinase inhibitors containing a C-terminal sulfo group. J Med Chem. 1992 Feb 7;35(3):602-8. PubMed PMID: 1738153. 11: Singh RL, Khana SK, Singh GB. Metabolic disposition of 14C-metanil yellow in guinea pigs. Vet Hum Toxicol. 1991 Jun;33(3):220-3. PubMed PMID: 1858299. 12: Srivastava LP, Khanna SK, Singh GB, Murti CR. In vitro studies on the biotransformation of metanil yellow. Environ Res. 1982 Feb;27(1):185-9. PubMed PMID: 7067676.